Unless you've recently returned to earth from a distant planet, you'll be aware of the momentum behind adoption of continuous manufacturing (CM) in pharma and its close relative, Flow Chemistry. Our team have been active in this area for more than two decades and if you're part of our user community you will know about the relevant equipment, properties and kinetic modeling tools we provide.
We've been attending some of the higher profile CM events and also developing additional tools to help manage specific risks. Here are some links to talks we saw at two events this year that we hope you find useful:
From the ISPE one-day meeting, CONTINUOUS MANUFACTURING – THE FUTURE OF PHARMACEUTICALS?, held in Cork, Ireland in late May:
From the FDA-AIChE Workshop on Adoption of Continuous Manufacturing: held in Bethesda, Maryland at the end of February:
Simulation of the response of a CM system to disturbance, using CM synthesis of Ibuprofen as an example. |
From the ISPE one-day meeting, CONTINUOUS MANUFACTURING – THE FUTURE OF PHARMACEUTICALS?, held in Cork, Ireland in late May:
- link to the official event site
- link to a folder containing the available talks in PDF format
From the FDA-AIChE Workshop on Adoption of Continuous Manufacturing: held in Bethesda, Maryland at the end of February:
- link to the official event site
- link to a folder containing the available talks in PDF format